List of insiders holdings for Adverum Biotechnologies Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Leonard Braden Michael 10% Owner |
2025-04-02 18:07:02 | 141,800 2,757,526 |
2,899,326 | Form 4 |
| 2 | Zygtech LLC 10% Owner |
2015-04-15 17:25:58 | 2,438,176 0 |
2,438,176 | Form 4 |
| 3 | Venrock Associates VI L.P. Venrock Partners VI L.P. Venrock Management VI LLC Venrock Partners Management VI LLC VENROCK HEALTHCARE CAPITAL PARTNERS LP VHCP Co-Investment Holdings LLC VHCP Management LLC Hove Anders D Koh Bong Y 10% Owner |
2014-08-07 15:17:11 | 0 2,365,471 |
2,365,471 | Form 4 |
| 4 | Venrock Associates VI L.P. Venrock Partners VI L.P. Venrock Management VI LLC Venrock Partners Management VI LLC VENROCK HEALTHCARE CAPITAL PARTNERS LP VHCP Co-Investment Holdings LLC VHCP Management LLC ROBERTS BRYAN E Hove Anders D 10% Owner |
2014-07-30 16:29:46 | 0 1,965,471 |
1,965,471 | Form 3 |
| 5 | REGENERON PHARMACEUTICALS INC 10% Owner |
2022-02-11 16:07:29 | 1,809,098 0 |
1,809,098 | Form 13G |
| 6 | Venrock Healthcare Capital Partners II L.P. VHCP Co-Investment Holdings II LLC VHCP Management II LLC 10% Owner |
2015-02-13 16:41:38 | 1,382,735 0 |
1,382,735 | Form 13G |
| 7 | Chalberg Thomas W. Chief Executive Officer |
2015-06-11 18:21:39 | 258,988 840,413 |
1,099,401 | Form 4 |
| 8 | Russo Carlo EVP and Chief Medical Officer |
2016-05-13 17:48:19 | 781,991 0 |
781,991 | Form 4 |
| 9 | Blumenkranz Mark S. Director |
2016-02-17 17:37:21 | 543,227 31,593 |
574,820 | Form 4 |
| 10 | Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant IV Luxco S.a r.l. Versant Capital IV (Switzerland) GmbH 10% Owner |
2024-05-14 17:06:37 | 500,387 0 |
500,387 | Form 13D |
| 11 | Salzman Amber President and CEO |
2018-02-20 19:15:32 | 478,000 0 |
478,000 | Form 4 |
| 12 | Schwartz Steven Daniel Director |
2017-06-14 19:07:11 | 432,593 0 |
432,593 | Form 4 |
| 13 | DeRespino Christopher See Remarks |
2021-06-29 18:53:32 | 425,000 0 |
425,000 | Form 3 |
| 14 | Thedinga Angela Chief Technology Officer |
2021-08-10 21:25:16 | 270,000 0 |
270,000 | Form 4 |
| 15 | Barone Samuel B. SVP, Clinical Development |
2017-02-13 17:35:56 | 256,335 0 |
256,335 | Form 4 |
| 16 | Fischer Laurent CEO, PRESIDENT AND DIRECTOR |
2025-02-27 16:05:11 | 246,614 0 |
246,614 | Form 4 |
| 17 | Rubio Roman G. SVP, Translational Medicine |
2016-02-17 17:31:11 | 240,650 0 |
240,650 | Form 4 |
| 18 | PATTERSON LEONE D President and CFO |
2021-02-18 21:03:54 | 240,000 0 |
240,000 | Form 4 |
| 19 | Beckman Richard Chief Medical Officer |
2023-03-03 17:23:14 | 225,000 0 |
225,000 | Form 4 |
| 20 | GUERIN JOHN PATRICK Director 10% Owner |
2015-06-11 21:09:04 | 0 200,000 |
200,000 | Form 4 |
| 21 | Clark Julie Chief Medical Officer |
2021-10-04 17:36:15 | 164,723 0 |
164,723 | Form 4 |
| 22 | Braun Shirley VP, Human Resources |
2016-02-17 17:26:09 | 161,140 0 |
161,140 | Form 4 |
| 23 | Countouriotis Athena SVP, Chief Medical Officer |
2018-02-20 19:16:22 | 160,000 0 |
160,000 | Form 4 |
| 24 | Osborne Aaron Chief Medical Officer |
2021-02-18 21:04:39 | 150,000 0 |
150,000 | Form 4 |
| 25 | Hull Hans Chief Executive Officer |
2015-08-25 17:09:21 | 137,210 0 |
137,210 | Form 4 |
| 26 | Soparkar Peter CHIEF OPERATING OFFICER |
2025-02-27 16:05:15 | 120,864 0 |
120,864 | Form 4 |
| 27 | Leung Thomas Chief Financial Officer |
2020-02-21 19:17:15 | 120,000 0 |
120,000 | Form 4 |
| 28 | Rakow John SVP, Genl Counsel, Acting CFO |
2022-09-16 19:00:02 | 118,070 0 |
118,070 | Form 4 |
| 29 | Riley Brigit Chief Scientific Officer |
2023-03-17 18:02:59 | 117,435 0 |
117,435 | Form 4 |
| 30 | Swartzburg Michael Principal Accounting Officer |
2016-02-17 17:28:24 | 82,113 0 |
82,113 | Form 4 |
| 31 | Cheng Jennifer C. General Counsel |
2019-02-19 16:17:54 | 80,000 0 |
80,000 | Form 4 |
| 32 | Wachter Paul Director |
2016-03-02 17:12:24 | 31,951 37,161 |
69,112 | Form 4 |
| 33 | Rubinstein Linda M CHIEF FINANCIAL OFFICER |
2025-02-27 16:05:10 | 68,075 0 |
68,075 | Form 4 |
| 34 | Seyedkazemi Setareh CHIEF DEVELOPMENT OFFICER |
2025-02-27 16:05:12 | 63,442 0 |
63,442 | Form 4 |
| 35 | Ozden Rabia Gurses Chief Medical Officer |
2025-02-27 16:05:13 | 56,875 0 |
56,875 | Form 4 |
| 36 | MCLAUGHLIN JOHN PETER Director |
2016-02-17 17:42:42 | 22,238 26,560 |
48,798 | Form 4 |
| 37 | Spivey Richard N. Director |
2019-08-02 16:26:55 | 45,000 0 |
45,000 | Form 4 |
| 38 | Bain Linda Chief Financial Officer |
2015-08-25 17:00:49 | 41,930 0 |
41,930 | Form 4 |
| 39 | Gasmi Mehdi Director |
2021-05-14 20:01:59 | 40,000 0 |
40,000 | Form 4 |
| 40 | Woiwode Thomas Director |
2021-05-14 20:05:38 | 40,000 0 |
40,000 | Form 4 |
| 41 | Cleveland Paul B Director |
2018-06-15 16:25:24 | 35,000 0 |
35,000 | Form 4 |
| 42 | Carter Eric G Director |
2020-06-25 17:44:15 | 30,000 0 |
30,000 | Form 4 |
| 43 | Hemrajani Rekha Director |
2020-06-25 17:45:04 | 30,000 0 |
30,000 | Form 4 |
| 44 | Kiss Szilard Director |
2024-06-20 16:43:07 | 21,040 0 |
21,040 | Form 4 |
| 45 | D'Souza Rupert Chief Financial Officer |
2022-05-17 18:28:44 | 20,850 0 |
20,850 | Form 4 |
| 46 | Machado Patrick Director |
2024-06-20 16:43:59 | 13,820 0 |
13,820 | Form 4 |
| 47 | Lupher Jr. Mark L. Director |
2024-06-20 16:48:15 | 10,520 0 |
10,520 | Form 4 |
| 48 | Nicholson C. David Director |
2024-06-20 16:49:31 | 10,520 0 |
10,520 | Form 4 |
| 49 | Hong Soo Director |
2024-06-20 16:48:45 | 10,520 0 |
10,520 | Form 4 |
| 50 | Svoronos Dawn Director |
2024-06-20 16:47:26 | 10,520 0 |
10,520 | Form 4 |
| 51 | Tuckson Reed Vaughn Director |
2024-06-20 16:46:36 | 10,520 0 |
10,520 | Form 4 |
| 52 | Whitcup Scott M Director |
2024-06-20 16:45:42 | 10,520 0 |
10,520 | Form 4 |
| 53 | Scopa James Paul Director |
2024-06-20 16:44:59 | 10,520 0 |
10,520 | Form 4 |
| 54 | PECOTA NANCY E Principal Accounting Officer |
2022-06-07 19:11:36 | 0 0 |
0 | Form 3 |
| 55 | Finer Mitchell H. Former Director Director |
2019-10-25 16:05:56 | 0 0 |
0 | Form 4/A |
| 56 | THRIFT JACK ANTHONY Interim CFO |
2021-09-13 17:49:31 | 0 0 |
0 | Form 3 |
| 57 | Flynn James E Deerfield Mgmt L.P. Deerfield Special Situations Fund L.P. Deerfield Special Situations International Master Fund L.P. Deerfield Mgmt III L.P. DEERFIELD MANAGEMENT CO Deerfield Private Design Fund III L.P. DEERFIELD PARTNERS LP Deerfield International Master Fund L.P. Possible Members of 10% Group 10% Owner |
2016-02-16 08:25:36 | 0 0 |
0 | Form 13G |